Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Peripheral Nervous System Diseases 3Pain 3Neurotoxicity Syndromes 1Neoplasms 1Cancer Pain 1Acute Pain 1

Interventions

Ketamine 2Gabapentin 2Diclofenac 2Anesthesia, General 2Acetaminophen 2Tea 1Quality of Life 1Pregabalin 1Passive Cutaneous Anaphylaxis 1Oxycodone 1Minocycline 1Meloxicam 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1Hydromorphone 1Ethyl Chloride 1Epinephrine 1Duloxetine Hydrochloride 1Diathermy 1Dexmedetomidine 1Cryotherapy 1Bupivacaine 1Anti-Inflammatory Agents, Non-Steroidal 1Analgesia, Patient-Controlled 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Acute Pain × Duloxetine Hydrochloride × Clear all
NCT03560427 2020-03-18

Duloxetine Potentiates the Analgesic Efficacy of Intrathecal Morphine

Assiut University

Phase NA Completed
60 enrolled

Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡